Jen-Tse Cheng

1.4k total citations
28 papers, 1.0k citations indexed

About

Jen-Tse Cheng is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jen-Tse Cheng has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 12 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jen-Tse Cheng's work include Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers), Renal Diseases and Glomerulopathies (8 papers) and Neurological and metabolic disorders (4 papers). Jen-Tse Cheng is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers), Renal Diseases and Glomerulopathies (8 papers) and Neurological and metabolic disorders (4 papers). Jen-Tse Cheng collaborates with scholars based in United States. Jen-Tse Cheng's co-authors include Vivette D. D’Agati, Laura Carbone, G Appel, Gerald B. Appel, Glen S. Markowitz, Sumit Mohan, Donald A. Feinfeld, Robert B. Colvin, Thomas Kahn and Velvie A. Pogue and has published in prestigious journals such as Journal of Clinical Investigation, American Journal of Epidemiology and Kidney International.

In The Last Decade

Jen-Tse Cheng

27 papers receiving 986 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jen-Tse Cheng United States 14 401 321 249 246 152 28 1.0k
T. K. Sreepada Rao United States 15 468 1.2× 544 1.7× 319 1.3× 204 0.8× 241 1.6× 27 1.2k
Minoru Ando Japan 25 387 1.0× 273 0.9× 207 0.8× 283 1.2× 219 1.4× 99 1.6k
G Zilleruelo United States 13 322 0.8× 105 0.3× 51 0.2× 89 0.4× 104 0.7× 30 658
Kenneth J. Wilkins United States 19 115 0.3× 188 0.6× 77 0.3× 242 1.0× 239 1.6× 46 1.0k
Dominik Jarczak Germany 18 118 0.3× 279 0.9× 133 0.5× 234 1.0× 478 3.1× 56 1.3k
Julius J. Schmidt Germany 19 113 0.3× 248 0.8× 61 0.2× 100 0.4× 338 2.2× 55 946
Michael Heifets United States 15 112 0.3× 195 0.6× 38 0.2× 56 0.2× 201 1.3× 25 797
Mehmet Davutoğlu Türkiye 16 48 0.1× 121 0.4× 49 0.2× 76 0.3× 157 1.0× 49 614
Edwin H. Eigenbrodt United States 19 56 0.1× 84 0.3× 50 0.2× 55 0.2× 292 1.9× 34 855
E Lauritzen Denmark 9 192 0.5× 132 0.4× 28 0.1× 59 0.2× 92 0.6× 14 774

Countries citing papers authored by Jen-Tse Cheng

Since Specialization
Citations

This map shows the geographic impact of Jen-Tse Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jen-Tse Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jen-Tse Cheng more than expected).

Fields of papers citing papers by Jen-Tse Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jen-Tse Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jen-Tse Cheng. The network helps show where Jen-Tse Cheng may publish in the future.

Co-authorship network of co-authors of Jen-Tse Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jen-Tse Cheng. A scholar is included among the top collaborators of Jen-Tse Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jen-Tse Cheng. Jen-Tse Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hor, Chee Peng, et al.. (2023). MORBIDITY AND MORTALITY OUTCOMES FOR PATIENTS WITH MODERATE-TO-SEVERE COVID-19 DISEASES: A POST-HOSPITALIZATION FOLLOW-UP STUDY. International Journal of Infectious Diseases. 130. S152–S153.
2.
Mohan, Sumit, Leal Herlitz, Jennifer Tan, et al.. (2013). The changing pattern of glomerular disease in HIV and Hepatitis C co-infected patients in the era of HAART. Clinical Nephrology. 79(4). 285–291. 14 indexed citations
3.
Mohan, Sumit, et al.. (2012). Identifying Hemodialysis Catheter Recirculation Using Effective Ionic Dialysance. ASAIO Journal. 58(5). 522–525. 15 indexed citations
4.
Mujtaba, Muhammad A., et al.. (2012). Toxicokinetics of metformin-associated lactic acidosis with continuous renal replacement therapy. European Journal of Drug Metabolism and Pharmacokinetics. 37(4). 249–253. 8 indexed citations
5.
Mohan, Sumit, et al.. (2010). Effective Ionic Dialysance/Blood Flow Rate Ratio: An Indicator of Access Recirculation in Arteriovenous Fistulae. ASAIO Journal. 56(5). 427–433. 13 indexed citations
6.
Mohan, Sumit, et al.. (2010). The Case ∣ 41-year-old HIV patient with proteinuria and progressive renal dysfunction. Kidney International. 77(5). 475–476. 12 indexed citations
7.
Mohan, Sumit, et al.. (2009). Influence of concomitant prednisolone on trimethoprim-associated hyperkalaemia. Journal of Antimicrobial Chemotherapy. 64(4). 850–852. 6 indexed citations
8.
Madhrira, Machaiah, Sumit Mohan, Glen S. Markowitz, Velvie A. Pogue, & Jen-Tse Cheng. (2008). Acute bilateral renal infarction secondary to cocaine-induced vasospasm. Kidney International. 76(5). 576–580. 17 indexed citations
9.
Mohan, Sumit, et al.. (2008). Hypokalemia During Sickle Cell Crises Apparently Due to Intermittent Mineralocorticoid Excess. American Journal of Kidney Diseases. 51(2). 319–325. 2 indexed citations
10.
Mohan, Sumit, et al.. (2007). Proteinuria lowers the risk of amphotericin B-associated hypokalaemia. Journal of Antimicrobial Chemotherapy. 60(3). 690–693. 5 indexed citations
11.
Mohan, Sumit, et al.. (2006). Unusual Biopsy Findings in a Hepatitis C–Infected White Man With Cryoglobulinemia, Purpuric Rash, and Renal Failure. American Journal of Kidney Diseases. 48(3). 513–517. 1 indexed citations
12.
Cheng, Jen-Tse, Sumit Mohan, Samih H. Nasr, & Vivette D. D’Agati. (2006). Chyluria presenting as milky urine and nephrotic-range proteinuria. Kidney International. 70(8). 1518–1522. 37 indexed citations
13.
Markowitz, Glen S., Punit Kaur, Attilio Orazi, et al.. (2001). A 51-Year-Old Female With Nephrotic Syndrome, Renal Failure, and Hepatitis C Virus Infection. American Journal of Kidney Diseases. 37(2). 442–447. 1 indexed citations
14.
Markowitz, Glen S., et al.. (1998). Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy.. Journal of the American Society of Nephrology. 9(12). 2244–2252. 117 indexed citations
15.
Feinfeld, Donald A., et al.. (1996). Effect of Oral L-Carnitine on Serum Myoglobin in Hemodialysis Patients. Renal Failure. 18(1). 91–96. 18 indexed citations
16.
Feinfeld, Donald A., et al.. (1992). A prospective study of urine and serum myoglobin levels in patients with acute rhabdomyolysis.. PubMed. 38(4). 193–5. 55 indexed citations
17.
Carbone, Laura, Vivette D. D’Agati, Jen-Tse Cheng, & Gerald B. Appel. (1989). Course and prognosis of human immunodeficiency virus-associated nephropathy☆. The American Journal of Medicine. 87. 389–395. 8 indexed citations
18.
Carbone, Laura, et al.. (1989). Course and prognosis of human immunodeficiency virus-associated nephropathy. The American Journal of Medicine. 87(4). 389–395. 132 indexed citations
19.
D’Agati, Vivette D., et al.. (1989). Pathology of HIV-associated nephropathy: A detailed morphologic and comparative study. Kidney International. 35(6). 1358–1370. 278 indexed citations
20.
Cheng, Jen-Tse, Thomas Kahn, & D. M. Kaji. (1984). Mechanism of alteration of sodium potassium pump of erythrocytes from patients with chronic renal failure.. Journal of Clinical Investigation. 74(5). 1811–1820. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. K. Sreepada Rao Breakdown of academic impact, for papers by Minoru Ando Breakdown of academic impact, for papers by G Zilleruelo Breakdown of academic impact, for papers by Kenneth J. Wilkins Breakdown of academic impact, for papers by Dominik Jarczak Breakdown of academic impact, for papers by Julius J. Schmidt Breakdown of academic impact, for papers by Michael Heifets Breakdown of academic impact, for papers by Mehmet Davutoğlu Breakdown of academic impact, for papers by Edwin H. Eigenbrodt Breakdown of academic impact, for papers by E Lauritzen
Rankless by CCL
2026